SciELO - Scientific Electronic Library Online

 
vol.59 número3Uso de Psicofármacos en la Región del Noreste Argentino durante la década de 2004-2013Estudios efectivos de potencial para algunas nuevas moléculas híbridas para su actividad contra el cáncer de próstata índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Ars Pharmaceutica (Internet)

versão On-line ISSN 2340-9894

Resumo

NARA, Sukanya  e  GARLAPATI, Achaiah. Design, Synthesis and molecular docking study of hybrids of quinazolin-4(3H)-one as anticancer agents. Ars Pharm [online]. 2018, vol.59, n.3, pp.121-131. ISSN 2340-9894.  http://dx.doi.org/10.30827/ars.v59i3.7360.

A series of 4-(2-(4-substituted phenyl)-4-oxoquinazolin-3(4H)-yl)-N-(2-(4-fluorophenyl)-4-oxo-5-(arylidene)thiazolidin-3-yl) benzamides (VIa-n) have been synthesized by condensation of N-(2-(4-fluorophenyl)-4-oxothiazolidin-3-yl)-4-(4-oxo-2-(4-substituted phenyl)quinazolin-3(4H)-yl)benzamides (Va-b) with various aryl/heteroaryl aldehydes using conventional methodology. All compounds were screened for their in vitro anticancer activity against the human breast cancer cell lines (MCF-7), human lung cancer cell lines (A549) using MTT assay method and doxorubicin is used as standard drug. Compound VId, VIk and VIn showed high potency against A549 cell lines with IC50 values 0.035±0.002 µM, 0.031±0.002 µM and 0.030±0.002 µM respectively compared to 0.023±0.002 µM showed by the standard. However, highest activity against MCF-7 cell lines was exhibited by Va, Vb, VIk and VIn with IC50 values between 0.040 - 0.050 µM. All the remaining compounds showed moderate anticancer activity against both the MCF-7 and A549 cell lines. To understand the interactions with active binding site of receptor, molecular docking study was also performed.

Palavras-chave : Quinazolin-4(3H)-one; Thiazolidin-4-one; Anticancer activity; Molecular docking.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )